维普中文期刊产品整合服务
637篇 您的检索式:期刊名="Int Clin Psychopharmacol"
    题名 作者 年代 出处 被引量
1Tardive dyskinesia and an - tipsychotics: a 5 - year longitudinal study of frequency, ~orrelates and course 显示文摘Eberhard J Lindstrom E Levander S 2006Int Clin Psychopharmacol2006,21,1:1
2Antipsychotic drugs and QT prolongation显示文摘Stollberger C Huber JO Finsterer J 2005Int Clin Psychopharmacol2005,20,5:1
3Aripiprazole as an augmentor of selective serotonin reuptake inhibitors in depression and anxiety disorder patients 显示文摘Worthington JJ Kinrys G Wygant LE 2005Int Clin Psychopharmacol2005,20,:1
4Treatment of generalized anxiety disorder with citalopram 显示文摘Varia I Rauscher F 2002Int Clin Psychopharmacol2002,17,3:1
5A double-blind Comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia显示文摘Clerc GE Ruimy P Verdeau-Palles J 1994Int Clin Psychopharmacol1994,9,:1
6Paliperidone extendedrelease tablet s in schizophrenia patients previously treated with risperidone 显示文摘CANUSO C M YOUSSEF E A BOSSIE C A 2008Int Clin Psychopharmacol2008,23,4:1
7A double-blind, randomized comparative trail of amisulpride versus olanzapine for 6 months in the treatment of schizophrenzia显示文摘Mortimer A Martin S Loo HH 2004Int Clin Psychopharmacol2004,19,2:1
8The effects of mirtazapine on centran noradrenergic and serotonergic neurotransmission 显示文摘De Boer T 1995Int clin Psychopharmacol1995,10,4:1
9eitalopram in major depressive disorder显示文摘Fantino Moore Verdoux Cost-effectiveness of escitalopram vs 2007Int Clin Psychopharmacol2007,22,2:1
10Serum adiponectin concent rations during treatment with olanzapine or risperidone: a pilot study 显示文摘Togo T Kojima K Shoji M 2004Int Clin Psychopharmacol2004,19,1:1
11Selective serotonin reuptake inhibitor use and bone mineral density in women with a history of depression显示文摘Williams L J Henry M J Berk M 2008Int Clin Psychopharmacol2008,23,2:1
12The effects of mirtszapine on central noradrenergic and serotonergic neurotranmfission显示文摘De Boer T 1995Int Clin Psychopharmacol1995,10,4:1
13Antioxidant enzyme activities and oxidative stress in affective disorders显示文摘Ozcan M E Gulec M Ozerol E 2004Int Clin Psychopharmacol2004,19,:1
14Evaluation of the effect of duloxetine treatment on functioning as measured by the Sheehan disability scale : pooled analysis of data from six random- ized, double - blind, placebo - controlled clinical studies显示文摘Mancini M Sheehan DV Demyttenaere K 2012Int Clin Psychopharmacol2012,27,6:1
15Efficacy of pharmacotherapy against core traits of borderline personality disorder:meta-analysis of randomized controlled trials显示文摘Nose M Cipriani A Biancosino B 2006Int Clin Psychopharmacol2006,21,:1
16Prevention of posts- troke depression with milnacipranin patients with acute ischemic stroke:a double - blind randomized placebo - controlled trial 显示文摘Tsai CS Wu CL Chou SY 2011Int Clin Psychopharmacol2011,26,5:1
17Efficacy and tolerability of Ziprasidone in patients with treatment - resistant schizophrenia 显示文摘Kane Jm Knanna S Rajadhyakshas 2006Int Clin Psychopharmacol2006,21,1:1
18Safety and tolerance profile of venlafaxine 显示文摘Danjou P Hackett D 1995Int Clin Psychopharmacol1995,10,2:1
19Effects of antipsychotic medications on sleep in schizophrenia 显示文摘Krystal AD Goforth HW Roth T 2008Int Clin Psychopharmacol2008,23,:1
20Serum adiponectin concentrations during treatment with olanzapine or risperidone: a pilot study显示文摘 Kojima K Shoji M Kase A Uchikado H Katasuse O 2004Int Clin Psychopharmacol2004,19,1:1
返回顶部 每页显示:
共32页 首页 上一页 第1页 下一页 末页 /32 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费